Michelle H. Cameron
Dr. Michelle Cameron is a neurologist and a physical therapist. She combines her neurology and rehabilitation expertise in patient care, treating people with multiple sclerosis (MS); in research, studying falls, mobility, and the use of cannabis and cannabinoids in people living with MS, and the use of physical agents in rehabilitation; and in education, teaching in person, virtually, and through publication, on MS, physical agents, and medical uses of cannabis and cannabinoids.
MY LATEST PUBLICATIONS & PRESENTATIONS
Judd GI, Hildebrand AD, Goldman MD, Cameron MH. Relationship between balance confidence and social engagement in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2022;57:103440.
Cameron M, McMillan G, Hugos C, Hildebrand A, Judd G, Jacobs P. Free From Falls education and exercise program for reducing falls in people with multiple sclerosis: a randomized controlled trial. Multiple Sclerosis Journal. 2021, Epub ahead of print.
Hildebrand A, Jacobs PG, Mosquera-Lopez C, Folsom JG, Wan E, Cameron MH. Comparing fall detection methods in people with multiple sclerosis: a prospective observational cohort study. Multiple Sclerosis and Related Disorders. 2021;56:103270.
Cohen J, Cameron MH, Goldman MD, Goodman AD, Miller AE, Rollins A, Llorens L, Patni R, Elfon R, Johnson R. A phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. Multiple Sclerosis Journal. 2021; Epub ahead of print.
Rice J, Hildebrand A, Spain R, Senders A, Silbermann E, Wooliscroft L, Yadav V, Bourdette D, Cameron M. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington. Multiple Sclerosis and Related Disorders. 2021;55:103172.
Rice J, Hildebrand A, Waslo C, Cameron M, Jones KD. Cannabis for medical purposes: a cross-sectional analysis of health care professionals’ knowledge. Journal of the American Association of Nurse Practitioners. 2021;34(1):100-106.
Cameron MH. Physical Agents in Rehabilitation: An Evidence-Based Approach to Practice. Philadelphia, PA: W. B. Saunders Company. 6th edition 2022, now also available in Spanish, Portuguese, Chinese, Japanese and Greek.
Medical marijuana for MS symptom management
Webinar with CME for VA MS Center of Excellence and National MS Society, December 2021
Risky movement: Data-driven fall-risk assessments for targeted care in people with MS
Kushner T, Mosquera-Lopez C, Cameron M, Jacobs P
Platform, Oregon Bioengineering Symposium, Portland, OR. November 2021
Spasticity experience in adults with multiple sclerosis: An integrated conceptual model
Wagner J, Cameron M, Bethoux F, Field-Fote E, Lenderking W, Zaiser E, Cutts K, Steinerman J
Presented platform at Consortium of MS Centers annual meeting, Orlando, FL. October 2021
Adapting One-on-One Rehabilitation Research to Prevent Falls in People with MS to the Virtual Environment: A COVID-19 Silver Lining
Cameron M, Hildebrand A, Serdar A, Schlimgen K, Scanlan K, Hugos C
ePoster at International Symposium on Gait and Balance in MS, Denver, CO. September 2021
Physical agents in rehabilitation
Throughout US and International
Clinical cannabis for the health care provider: Best practices
Program co-chair and presenter
Portland, OR, 2018 & 2019